Find a Therapeutic By Name

Search By Attributes

Therapy Type

Combination
DNA/RNA-based
Immunotherapy (active)
Immunotherapy (passive)
Other
Procedural Intervention
Small Molecule
Supplement, Dietary

Condition

Alzheimer's Disease
Amyotrophic Lateral Sclerosis
Cerebral Amyloid Angiopathy
Frontotemporal Dementia
Mild Cognitive Impairment
Parkinson's Disease

Keyword

1 Therapeutic

Search Results

Name	Synonyms	FDA Status	Company	Target Type	Therapy Type	Approved For
HMTM	LMTM, LMTX, LMT-X, TRx0237, Tau aggregation inhibitor (TAI), Methylene Blue	Alzheimer's Disease (Phase 3), Frontotemporal Dementia (Phase 3)	TauRx Therapeutics Ltd	Tau	Small Molecule	Methylene Blue predates FDA. Used for treatment of malaria and methemoglobinemia.